Drug profile

The FDA adverse-event record for Misoprostol

141 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Misoprostol. See the species affected, top reactions, and outcomes below.

141
adverse-event reports
16.3%
death-coded share
Horse
most-reported species
56
Lack of efficacy - NOS - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
141
Total Reports
23
Deaths Reported
16.3%
Death Rate

Active Ingredients

Misoprostol

Administration Routes

UnknownOral

Species Affected

Horse 77
Dog 61
Cat 2
Donkey 1

Most Affected Breeds

Retriever - Labrador 18
Warmblood (unspecified) 17
Quarter Horse 13
Horse (unknown) 12
Thoroughbred 7
Arab 4
Paint 4
Shepherd (unspecified) 3
Siberian Husky 3
Mixed (Dog) 2

Most Reported Reactions

Lack of efficacy - NOS 56
Vomiting 25
INEFFECTIVE, GASTRIC ULCER(S) 23
Lethargy (see also Central nervous system depression in 'Neurological') 20
Death by euthanasia 19
Anorexia 17
Elevated alanine aminotransferase (ALT) 17
Elevated serum alkaline phosphatase (SAP) 16
Diarrhoea 16
Anaemia NOS 15
Other abnormal test result NOS 15
Hypoproteinaemia 12

Outcome Breakdown

Outcome Unknown
54 (38.3%)
Ongoing
43 (30.5%)
Recovered/Normal
20 (14.2%)
Euthanized
19 (13.5%)
Died
4 (2.8%)
Recovered with Sequela
1 (0.7%)

Misoprostol Adverse Event Insights

141 reports name Misoprostol; 23 recorded a death outcome (16.3% of reported events, not a population-level mortality rate). Active ingredient: Misoprostol. Administration routes: Unknown, Oral.

By species: Horse (77 reports), Dog (61 reports), Cat (2 reports). By breed: Retriever - Labrador (18), Warmblood (unspecified) (17), Quarter Horse (13).

Leading clinical signs: Lack of efficacy - NOS (56), Vomiting (25), INEFFECTIVE, GASTRIC ULCER(S) (23), Lethargy (see also Central nervous system depression in 'Neurological') (20). Outcome, 141 coded reports: Outcome Unknown leads at 38.3%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.